Impact of Type 2 diabetes and aging on cardiomyocyte function and O-linked N-acetylglucosamine levels in the heart - Wikidata - awgldk - TriplyDB

Impact of Type 2 diabetes and aging on cardiomyocyte function and O-linked N-acetylglucosamine levels in the heart

Impact of Type 2 diabetes and aging on cardiomyocyte function and O-linked N-acetylglucosamine levels in the heart

http://www.wikidata.org/entity/Q28276371

about

The role of glucosamine-induced ER stress in diabetic atherogenesis The role of O-GlcNAc transferase in regulating the gene transcription of developing and failing hearts O-GlcNAcylation and oxidation of proteins: is signalling in the cardiovascular system becoming sweeter?Mitochondria and oxidative stress in heart aging Aging leads to increased levels of protein O-linked N-acetylglucosamine in heart, aorta, brain and skeletal muscle in Brown-Norway rats O-linked β-N-acetylglucosamine supports p38 MAPK activation by high glucose in glomerular mesangial cells TNNI1, TNNI2 and TNNI3: Evolution, regulation, and protein structure-function relationships.Acute regulation of cardiac metabolism by the hexosamine biosynthesis pathway and protein O-GlcNAcylation.Consuming a Western diet for two weeks suppresses fetal genes in mouse hearts.Inhibition of O-GlcNAcase in perfused rat hearts by NAG-thiazolines at the time of reperfusion is cardioprotective in an O-GlcNAc-dependent manner.Activation of the hexosamine biosynthesis pathway and protein O-GlcNAcylation modulate hypertrophic and cell signaling pathways in cardiomyocytes from diabetic mice Z-band alternatively spliced PDZ motif protein (ZASP) is the major O-linked β-N-acetylglucosamine-substituted protein in human heart myofibrils Protein O-GlcNAcylation and cardiovascular (patho)physiology.High glucose induces mitochondrial dysfunction independently of protein O-GlcNAcylation.O-GlcNAcylation, novel post-translational modification linking myocardial metabolism and cardiomyocyte circadian clock.Cross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease.Anti-atherosclerotic effects of sitagliptin in patients with type 2 diabetes mellitus.The roles of O-linked β-N-acetylglucosamine in cardiovascular physiology and disease.Chronic ingestion of a Western diet increases O-linked-β-N-acetylglucosamine (O-GlcNAc) protein modification in the rat heart.Andropause and the development of cardiovascular disease presentation-more than an epi-phenomenon.Removal of Abnormal Myofilament O-GlcNAcylation Restores Ca2+ Sensitivity in Diabetic Cardiac Muscle.Glucose deprivation-induced increase in protein O-GlcNAcylation in cardiomyocytes is calcium-dependent Excess protein O-GlcNAcylation and the progression of diabetic cardiomyopathy.Cardiac O-GlcNAcylation blunts autophagic signaling in the diabetic heart Modification of STIM1 by O-linked N-acetylglucosamine (O-GlcNAc) attenuates store-operated calcium entry in neonatal cardiomyocytes Impact of O-GlcNAc on cardioprotection by remote ischaemic preconditioning in non-diabetic and diabetic patients.Activation of retinoid receptor-mediated signaling ameliorates diabetes-induced cardiac dysfunction in Zucker diabetic rats.Nonischemic heart failure in diabetes mellitus.Metabolic dysfunction in diabetic cardiomyopathy.O-linked GlcNAc modification of cardiac myofilament proteins: a novel regulator of myocardial contractile function.Protein O-GlcNAcylation: a new signaling paradigm for the cardiovascular system.Low carbohydrate diet decreases myocardial insulin signaling and increases susceptibility to myocardial ischemia.Interaction of diet and diabetes on cardiovascular function in rats The complexities of diabetic cardiomyopathy: lessons from patients and animal models.O-GlcNAcylation of AMPA receptor GluA2 is associated with a novel form of long-term depression at hippocampal synapses Differential hexosamine biosynthetic pathway gene expression with type 2 diabetes.The role of protein O-linked beta-N-acetylglucosamine in mediating cardiac stress responses.O-GlcNAc and the cardiovascular system.Protein O-linked β-N-acetylglucosamine: a novel effector of cardiomyocyte metabolism and function.Cardiac metabolism and its interactions with contraction, growth, and survival of cardiomyocytes.

P2860

Q26830592-B9690387-DE22-4E2C-AE4A-F8053F27A42B Q27005703-0176D294-95C0-4E11-8DAA-E0F9B9F3D1E5 Q27693206-B1C0F8C2-0FEA-4C62-88AD-C67EE0E98D17 Q28391449-EEAA83FB-2A3D-4666-9849-13543C5FA04E Q28568308-5DC7074D-8E64-4258-90DF-D4CE96A560BC Q28569862-8E82A446-50D3-40BA-80F8-F8839AE3D2F8 Q30380968-9728CB20-8682-475E-A14A-952830CCBC90 Q33873374-F4FB54DD-5485-41E5-8AED-2049490075F5 Q34000929-56BF3E6A-8A9F-4783-8FEC-22B2AB91FAD2 Q34357844-499DC1F4-E26F-440F-A881-C96FFF5CE49D Q34512181-BE09989C-00CF-4A2A-AA8F-EC9133E5B999 Q34524429-F11F3220-1C83-4D80-899A-9B3BFBC7B140 Q34683061-BA59A6D1-5ABA-4E27-959D-1D2B613F8F71 Q35535273-A8DE46A6-AF63-461E-8EB9-980C64B441E7 Q35639683-E4167BFB-A14B-49B9-8AB1-C0DC850BBE98 Q35804446-5C7A2EE7-D1F5-4FF9-9A3B-B28E6B1DB3B6 Q35914764-0EAD11C9-713E-4B81-B377-9511388DD61E Q35994096-72A80CE6-D47E-4515-8290-8899AB3F16DC Q36024572-6F64A8AF-E1EE-4E43-99CE-10AD374DDD71 Q36077239-948F6578-0B61-49FE-AF09-635F726C1B16 Q36104643-EC92131E-1A29-4A07-842C-166C2136D399 Q36298449-BC732783-7EF7-45E0-BEC2-B8368DBDF9D6 Q36312605-462837B7-B953-41B9-8BAF-1FE389DBCA7A Q36336533-42A5B322-C207-4155-AB43-ED0AC046FDAB Q36385967-5A414AD2-651E-4B65-855B-39E81E256E74 Q36647017-366CFE5B-2285-4A7D-9B95-B8EECB9D3AB3 Q36673848-94655951-1470-483B-8D65-72A842927AFA Q36762969-C94D788B-1B32-4116-8266-06C16D654035 Q36930481-9829B4D8-C81A-410C-B282-9E41057486F3 Q37040657-DF02856D-C89B-404B-B115-B899ADBECE71 Q37088282-5DAA9C20-A257-4FDA-B07C-F1850CA7C0A9 Q37097785-ED9CC2D0-25BB-4892-9B54-5BA210D998C1 Q37100156-F4B6AF17-A11A-4F30-86FA-53C47E468570 Q37215457-2C5DD460-C7CE-40C0-BEB7-1C057FF06A25 Q37399894-84073B1B-CA28-493F-AC8B-66D4CC144148 Q37434092-52916A7F-BD8C-4EE0-A30F-EDE2D469C8C3 Q37553107-5CF25EAE-9092-4DC7-AF05-0EE90A97290A Q37619691-BEB095C8-AC1B-40D2-B187-A8C40256849A Q37924015-823F0FB3-4982-4AF3-96FB-E3DEE88B4663 Q38129182-B8493426-DEB4-42CB-B5D3-671EE671E528

P2860

Impact of Type 2 diabetes and aging on cardiomyocyte function and O-linked N-acetylglucosamine levels in the heart

http://www.wikidata.org/entity/Q28276371

description

2007 nî lūn-bûn

@nan

2007 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Impact of Type 2 diabetes and ...... lucosamine levels in the heart

@ast

Impact of Type 2 diabetes and ...... lucosamine levels in the heart

@en

Impact of Type 2 diabetes and ...... lucosamine levels in the heart

@nl

type

label

Impact of Type 2 diabetes and ...... lucosamine levels in the heart

@ast

Impact of Type 2 diabetes and ...... lucosamine levels in the heart

@en

Impact of Type 2 diabetes and ...... lucosamine levels in the heart

@nl

prefLabel

Impact of Type 2 diabetes and ...... lucosamine levels in the heart

@ast

Impact of Type 2 diabetes and ...... lucosamine levels in the heart

@en

Impact of Type 2 diabetes and ...... lucosamine levels in the heart

@nl

P1433

Q28276371-FD57E275-7F9E-4A6C-93A4-745D030978B6

P1476

Q28276371-3EB368DD-BB7E-411F-AC0C-E8DCD3839CE1

P2093

Q28276371-1E634D7E-C8C2-4188-8EB5-81C43F1A3761

Q28276371-259E0363-F6A1-4114-8EA7-3DB7191C5A3F

Q28276371-A092E4ED-5B54-4623-B40B-19A04443DC40

Q28276371-A7C0E598-7B92-4AEC-A6E1-C9DA7E4529EF

Q28276371-DB91C6E2-94A5-4AB1-BCA2-0858C5454A65

Q28276371-F247CC83-4A51-4B36-8E6E-23F62A27E9EC

Q28276371-FBFBFC7A-49F6-472B-BFA2-98817146B64E

P2860

Q28276371-0B1FBEF6-9054-438C-A4D8-0E631D229A7E

Q28276371-0DCB4FB9-0CA2-4030-AFFF-8C8E6B09BF70

Q28276371-0FDE365F-665F-4FE0-8095-4AED6A113B99

Q28276371-147D987A-866D-4878-B0C3-D9A7030F43C2

Q28276371-18978B4D-BFDF-4ADB-8BD2-4C29BC98093D

Q28276371-27561354-83D5-417D-9BEE-517C38BA6C26

Q28276371-29C0980F-216E-424F-994C-A3B790A12A25

Q28276371-370F2D9B-CE05-43A6-9952-367AA8E22B54

Q28276371-450D910F-D062-4FB2-8D51-57CB891074F5

Q28276371-45F5B23D-DDD8-423C-AC8D-85B767E5F0C4

P304

Q28276371-26D54C0B-25BD-4B5D-90BD-9CAD8B464384

P31

Q28276371-685B873A-3974-4F57-818F-3C6DEF40639B

P3181

Q28276371-00FEAA93-AAAA-45BF-BA5E-35816E449266

P356

Q28276371-6734C2D3-8F5F-4A3C-A791-21C1AC5F4D03

P407

Q28276371-5A50023C-AA60-47C5-84B1-F87433B2FA0C

P433

Q28276371-3A4EB4EB-405E-4B1C-A36A-42FA2F48025A

P478

Q28276371-7EAAB2E9-65B9-4AA9-B4D4-AD1DD0E5B996

P577

Q28276371-F7C1716F-C484-451A-8F52-FD37BD447C56

P5875

Q28276371-7516F715-DE9F-4913-A079-742CF455FC88

P698

Q28276371-2A8F8E54-3780-40D5-8495-FA2860A50B0A

P921

Q28276371-48CE2FAB-04B2-4D98-976B-6F46887150B4

P3181

P356

AJPCELL.00422.2006

P1433

American Journal of Physiology - Cell Physiology

P1476

Impact of Type 2 diabetes and ...... lucosamine levels in the heart

@en

P2093

Amy J Davidoff

http://www.w3.org/2001/XMLSchema#string

John C Chatham

http://www.w3.org/2001/XMLSchema#string

Kaushik Dutta

http://www.w3.org/2001/XMLSchema#string

Meredith M Mason

http://www.w3.org/2001/XMLSchema#string

Norbert Fülöp

http://www.w3.org/2001/XMLSchema#string

Peipei Wang

http://www.w3.org/2001/XMLSchema#string

Richard B Marchase

http://www.w3.org/2001/XMLSchema#string

P2860

Biochemistry and molecular cell biology of diabetic complications

The hexosamine signaling pathway: deciphering the "O-GlcNAc code"

Glucosamine inhibits angiotensin II-induced cytoplasmic Ca2+ elevation in neonatal cardiomyocytes via protein-associated O-linked N-acetylglucosamine

Glucosamine protects neonatal cardiomyocytes from ischemia-reperfusion injury via increased protein-associated O-GlcNAc

Separation techniques for high-molecular-mass proteins.

The diabetic heart: metabolic causes for the development of a cardiomyopathy.

O-GlcNAc cycling: how a single sugar post-translational modification is changing the way we think about signaling networks.

Cardiac contractile dysfunction in Lep/Lep obesity is accompanied by NADPH oxidase activation, oxidative modification of sarco(endo)plasmic reticulum Ca2+-ATPase and myosin heavy chain isozyme switch.

Increased activity of the hexosamine synthesis pathway in muscles of insulin-resistant ob/ob mice.

O-GlcNAc modification is an endogenous inhibitor of the proteasome.

P304

C1370-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2355936

http://www.w3.org/2001/XMLSchema#string

P356

10.1152/AJPCELL.00422.2006

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

292

http://www.w3.org/2001/XMLSchema#string

P577

2007-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6664011

http://www.w3.org/2001/XMLSchema#string

P698

17135297

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes